Exact Sciences buy Benchmark Co.
Start price
15.03.23
/
50%
€59.64
Target price
15.03.24
€73.83
Performance (%)
-10.85%
End price
16.03.24
€53.17
Summary
This prediction ended on 16.03.24 with a price of €53.17. The price of Exact Sciences has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.85%. Benchmark_Co_ has a follow-up prediction for Exact Sciences where he still thinks Exact Sciences is a Buy. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Exact Sciences | - | - | - | - |
| iShares Core DAX® | -2,68 % | 4,26 % | 2,12 % | 57,51 % |
| iShares Nasdaq 100 | 0,73 % | 5,80 % | 34,20 % | 92,83 % |
| iShares Nikkei 225® | -0,73 % | 9,32 % | 61,30 % | 80,34 % |
| iShares S&P 500 | 1,17 % | 5,48 % | 24,75 % | 70,97 % |
Comments by Benchmark_Co_ for this prediction
In the thread Exact Sciences diskutieren
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at Benchmark Co. from $54.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
In the thread Trading Exact Sciences
Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten